| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥5.05B | +87.4% |
| Gross profit | ¥0.47B | — |
| Operating income | ¥0.26B | — |
| Net income | ¥0.23B | +81.8% |
| Gross margin | 9.3% | Net margin 4.6% |
| Revenue Q/Q | +14.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.58B | 90.7% |
| R&D | ¥0.07B | 1.4% |
| SG&A | ¥0.12B | 2.3% |
| Tax & other | ¥0.02B | 0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
金石亚药 ・ 中泰股份 ・ 广生堂 ・ 清水源 ・ 鹏辉能源 ・ 美康生物 ・ 运达科技 ・ 鲍斯股份 ・ 金雷股份 ・ 双杰电气 ・ 康斯特 ・ 航天智造
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies